13F

Stock

Sarepta Therapeutics, Inc.

SRPT · held by 19 managers

Reported value

$135.5M

Holders

19

+2 new · −2 exited

Holders’ est. mark

$4.66M

Price effect on 5 books still in the name

Largest holder

$63.3M

TUDOR INVESTMENT CORP ET AL

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
TUDOR INVESTMENT CORP ET AL68.8M$63.3MHeld
MORGAN STANLEY1.95M$37.5MHeld
BANK OF AMERICA CORP /DE/4.8M$19MHeld
BARCLAYS PLC299.1K$5.76M$4.56MCut−$2.48M
Boxer Capital Management, LLC250K$4.82M$54.2KAdded$4.39M
Hudson Bay Capital Management LP200K$3.85MHeld
VIRTUS ADVISERS, LLC25.8K$497.2KNew
PEAK6 LLC16K$308.1K$34.7KCut−$258K
Leonteq Securities AG11.4K$219.4K$14KAdded$109.4K
IFP Advisors, Inc4.74K$91.4KHeld
Essential Partners LLC3.05K$58.9KNew
Allworth Financial LP1.8K$34.7KHeld
MV CAPITAL MANAGEMENT, INC.82$1.58KHeld
Aventura Private Wealth, LLC7$135$15Added$15
Principia Wealth Advisory, LLC5$96Held
KBC Group NV3.15K$61Held
FNY Investment Advisers, LLC14$0Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.